Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Tobacco Use Cessation 1Tobacco Use 1Smoking Cessation 1HIV Seropositivity 1Acquired Immunodeficiency Syndrome 1

Interventions

Radiosurgery 58Radiotherapy 43Magnetic Resonance Spectroscopy 39Cyclophosphamide 34Standard of Care 30Surveys and Questionnaires 22Dexamethasone 19Educational Status 18Therapeutics 17Exercise 17Radiation 16Magnetic Resonance Imaging 16fludarabine phosphate 15Proton Therapy 15Practice Guidelines as Topic 15Methods 15Mammography 15Fluorodeoxyglucose F18 15Cisplatin 15Blood Specimen Collection 15Acupuncture Therapy 15Doxorubicin 14fludarabine 13Positron-Emission Tomography 13Calcium Dobesilate 13Biopsy 13Surgical Procedures, Operative 12Radiotherapy, Intensity-Modulated 12Palliative Care 12Indocyanine Green 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Has results × Tobacco Use Cessation Devices × Clear all
NCT02157610 2023-07-20

Smoking Cessation for Cervical Cancer Survivors

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
202 enrolled 8 charts
Gynecologic

Uterine Cervical Neoplasms, Smoking Cessation, Tobacco Use

NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡